Skip to Main Content

Lung Cancer Screening Improvement Collaborative

This Collaborative of the ACR® Learning Network seeks to significantly increase lung cancer screening volumes.

Join the Next Cohort 

Lung cancer is the leading cause of cancer death in the U.S., and currently up to 90% of eligible patients do not receive a low-dose computed tomography (LDCT) scan. If lung cancer is caught before it spreads, the likelihood of surviving 5 years or more improves to 61%, but only 4.5% of those who are eligible were screened in 2022. To increase screening volumes, participating facilities are supported in identifying and evaluating opportunities within scheduling processes, data collection and reporting, provider relationships, patient communication, and patient navigator responsibilities.  

Start your application
ACR Learning Network Lung Cancer Screening Quality Improvement Collaborative

Problem Statement

Lung Cancer Screening programs are underutilized by patients, possibly leading to missed opportunities for early cancer detection and management.

How the Collaborative Works

Loading component...

Loading component...

Collaborative Committee

  • Stephen Sevigny, MD
  • Ayis Pyrros, MD
  • Terrance Healey, MD
  • Sara Ghandehari, MD

Loading component...